Catalyst Wire Dossier Catalyst Wire Dossier

Gemcitabine hydrochloride and paclitaxel albumin-stabilized nanoparticle formulation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gemcitabine hydrochloride and paclitaxel albumin-stabilized nanoparticle formulation, covering 2021-07-23 to 2021-07-23. Get the full timeline:

Most recent: Clinical Trial Update: S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery [Phase 2]

See pricing